Omada Health, Inc. Overview
Pro stress-test →Omada Health (Nasdaq: OMDA) is reverse engineering the way healthcare is delivered in America, putting the space between doctor visits–where health is won or lost–at the center of care. The company serves 1.02 million total members, up 51% year over year, as an integrated, multi-condition cardiometabolic platform operating at scale. The platform addresses chronic conditions that require ongoing support outside of the exam room, like obesity, diabetes, hypertension, cholesterol, and musculoskeletal conditions.
Strategic Profile
Pro stress-test →Omada significantly outpaces competitors in monthly global app downloads with downloads approaching 80,000 by January 2026 compared to most competitors hovering around or below 20,000. The company differentiates its offering through multi-condition care, evidence with 30 peer-reviewed publications and four accreditations, compassionate intelligence combining care teams with technology, and scaled diversified go-to-market serving over 2,000 customers. In May 2026, Omada announced it will serve as an independent program administrator in Eli Lilly and Company's Employer Connect program, with GLP-1 Care Track available on the direct-to-employer platform.
Competitive Landscape
Pro stress-test →Omada significantly outpaces digital health competitors including Hello Heart, Virta, Vida, Twin, Lark, and Livongo in monthly app downloads. Key competitors compete in chronic disease management, virtual care, and GLP-1/weight management segments. Omada's multi-condition platform and embedded clinical expertise provide differentiation versus single-indication competitors.
Industry Context
Omada Health, Inc. operates in Digital Health / Virtual Care / Chronic Disease Management.
Key facts
Founded: 2011 · Headquarters: San Francisco, US · Employees: Not disclosed · Revenue: $78M (Q1 2026); FY 2025: $260.2M · Market cap: $942M